NKX2-5 and neuroendocrine neoplasm: A recent study performed by Kawasaki et al. [71] reported the establishment of a gastro-entero-pancreatic (GEP) neuroendocrine neoplasm (NEN) organoid biobank characterized by NKX2-5 expression and exhibiting WNT- and EGF-independent growth.